Segment reporting (Tables)

6 Months Ended

Feb. 29, 2020

Segment Reporting [Abstract]

Reconciliation of Operating Income (Loss) from Segments to Consolidated

The following table reflects results of operations of the Company's reportable segments (in millions):

	Three months ended				Six months ended
	February 29, 2020		February 28, 2019		February 29, 2020		February 28, 2019
Sales:
Retail Pharmacy USA	$	27,245	$	26,257	$	53,377	$	51,979
Retail Pharmacy International	3,056		3,082		5,801		5,982
Pharmaceutical Wholesale	6,066		5,738		12,072		11,446
Eliminations1	(546)		(549)		(1,091)		(1,086)
Walgreens Boots Alliance, Inc.	$	35,820	$	34,528	$	70,160	$	68,321
Adjusted Operating income:
Retail Pharmacy USA	$	1,267	$	1,455	$	2,423	$	2,834
Retail Pharmacy International	198		256		276		388
Pharmaceutical Wholesale	235		225		464		445
Eliminations1	2		(1)		2		—
Walgreens Boots Alliance, Inc.	$	1,703	$	1,935	$	3,166	$	3,667

¹Eliminations relate to intersegment sales between the Pharmaceutical Wholesale and the Retail Pharmacy International segments.

The following table reconciles adjusted operating income to operating income (in millions):

	Three months ended				Six months ended
	February 29, 2020		February 28, 2019		February 29, 2020		February 28, 2019
Adjusted operating income	$	1,703	$	1,935	$	3,166	$	3,667
Acquisition-related amortization and impairment	(117)		(123)		(235)		(246)
Acquisition-related costs	(99)		(82)		(223)		(148)
Transformational cost management	(123)		(150)		(209)		(179)
Adjustments to equity earnings in AmerisourceBergen	(73)		(9)		(152)		(54)
LIFO provision	(28)		(8)		(61)		(48)
Store optimization	(30)		(31)		(39)		(51)
Certain legal and regulatory accruals and settlements	—		(14)		—		(24)
Operating income	$	1,233	$	1,517	$	2,247	$	2,918